Codiak BioSciences CDAK Stock
Codiak BioSciences Price Chart
Codiak BioSciences CDAK Financial and Trading Overview
| Codiak BioSciences stock price | 0.06 USD |
| Previous Close | 0.06 USD |
| Open | 0.11 USD |
| Bid | 0.04 USD x 1200 |
| Ask | 0.04 USD x 3200 |
| Day's Range | 0.05 - 0.11 USD |
| 52 Week Range | 0.02 - 4.25 USD |
| Volume | 12.93M USD |
| Avg. Volume | 1.6M USD |
| Market Cap | 2.83M USD |
| Beta (5Y Monthly) | 3.934951 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9 USD |
CDAK Valuation Measures
| Enterprise Value | 14.28M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.041007195 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.08303314 |
| Price/Book (mrq) | 0.053926203 |
| Enterprise Value/Revenue | 0.419 |
| Enterprise Value/EBITDA | -0.296 |
Trading Information
Codiak BioSciences Stock Price History
| Beta (5Y Monthly) | 3.934951 |
| 52-Week Change | -99.49% |
| S&P500 52-Week Change | 4.08% |
| 52 Week High | 4.25 USD |
| 52 Week Low | 0.02 USD |
| 50-Day Moving Average | 0.41 USD |
| 200-Day Moving Average | 1 USD |
CDAK Share Statistics
| Avg. Volume (3 month) | 1.6M USD |
| Avg. Daily Volume (10-Days) | 3.03M USD |
| Shares Outstanding | 36.83M |
| Float | 19.63M |
| Short Ratio | 2.23 |
| % Held by Insiders | 0.47% |
| % Held by Institutions | 71.52% |
| Shares Short | 173.81K |
| Short % of Float | 0.64% |
| Short % of Shares Outstanding | 0.47% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2021 |
| Most Recent Quarter (mrq) | September 30, 2022 |
| Next Fiscal Year End | December 31, 2022 |
Profitability
| Profit Margin | -51.12% |
| Operating Margin (ttm) | -154.40% |
| Gross Margin | -60.89% |
| EBITDA Margin | -141.73% |
Management Effectiveness
| Return on Assets (ttm) | -22.43% |
| Return on Equity (ttm) | -47.76% |
Income Statement
| Revenue (ttm) | 34.07M USD |
| Revenue Per Share (ttm) | 1.47 USD |
| Quarterly Revenue Growth (yoy) | -54.90% |
| Gross Profit (ttm) | -41920000 USD |
| EBITDA | -48287000 USD |
| Net Income Avi to Common (ttm) | -17419000 USD |
| Diluted EPS (ttm) | -0.46 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 51.76M USD |
| Total Cash Per Share (mrq) | 1.41 USD |
| Total Debt (mrq) | 61.28M USD |
| Total Debt/Equity (mrq) | 157.41 USD |
| Current Ratio (mrq) | 4.236 |
| Book Value Per Share (mrq) | 1.057 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -67080000 USD |
| Levered Free Cash Flow (ttm) | -34323000 USD |
Profile of Codiak BioSciences
| Country | United States |
| State | MA |
| City | Cambridge |
| Address | 35 Cambridge Park Drive |
| ZIP | 02140 |
| Phone | 617 949 4100 |
| Website | https://www.codiakbio.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 102 |
Codiak BioSciences, Inc., a clinical-stage biopharmaceutical company, focuses on developing exosome-based therapeutics for the treatment of oncology, neuro-oncology, neurology, neuromuscular diseases, infectious diseases, and other diseases. Its lead product candidates are exoSTING and exoIL-12 exosome therapeutic candidates for the treatment of various solid tumors. The company is also developing exoASO-STAT6, an antisense oligonucleotide targeting the STAT6 transcription factor; and exoVACC, a modular platform for constructing precision vaccines. It has a collaboration agreement with the Jazz Pharmaceuticals Ireland Limited, Sarepta Therapeutics, Inc., Kayla Therapeutics S.A.S., Washington University, Ragon Institute of MGH, MIT, and Harvard. The company was incorporated in 2015 and is headquartered in Cambridge, Massachusetts. On March 27, 2023, Codiak BioSciences, Inc., along with its affiliate, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For Codiak BioSciences Stock
What is a current CDAK stock price?
Codiak BioSciences CDAK stock price today per share is 0.06 USD.
How to purchase Codiak BioSciences stock?
You can buy CDAK shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Codiak BioSciences?
The stock symbol or ticker of Codiak BioSciences is CDAK.
Which industry does the Codiak BioSciences company belong to?
The Codiak BioSciences industry is Biotechnology.
How many shares does Codiak BioSciences have in circulation?
The max supply of Codiak BioSciences shares is 0.
What is Codiak BioSciences Price to Earnings Ratio (PE Ratio)?
Codiak BioSciences PE Ratio is now.
What was Codiak BioSciences earnings per share over the trailing 12 months (TTM)?
Codiak BioSciences EPS is 0 USD over the trailing 12 months.
Which sector does the Codiak BioSciences company belong to?
The Codiak BioSciences sector is Healthcare.
Codiak BioSciences CDAK included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 16175.09 USD — |
-1.62
|
3.94B USD — | 16125.33 USD — | 16341.46 USD — | — - | 3.94B USD — |
| Stlmt ID NASDAQ Biotechnology NBX | 4604.4 USD — |
-2.98
|
— — | 4555.41 USD — | 4917.8 USD — | — - | — — |
| NASDAQ Global Market Composite NQGM | 2160.36 USD — |
-2.45
|
— — | 2147.48 USD — | 2200.33 USD — | — - | — — |
| NASDAQ Biotechnology NBI | 4195.13 USD — |
-2.14
|
— — | 4174.1 USD — | 4266.29 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 958.68 USD — |
-2.07
|
— — | 954.08 USD — | 972.42 USD — | — - | — — |
- {{ link.label }} {{link}}